AnaptysBio, Inc. Announces Agreement with Roche to Develop Novel Antibodies

January 11, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has signed an agreement with Roche for the development of novel antibody therapeutics.

Twitter
LinkedIn
Facebook
Email
Print

Alliances

AnaptysBio, Inc. Roche